期刊文献+

原发性胆汁性肝硬化患者树突状细胞中细胞因子及其信号转导抑制分子变化的意义 被引量:2

Expression of cytokines and suppressor of cytokine signaling in peripheral blood mononuclear cells derived dendritic cells from primary biliary cirrhosis patients
原文传递
导出
摘要 目的观察细胞因子信号转导抑制分子(SOCS)在原发性胆汁性肝硬化(PBC)患者树突状细胞(DC)及其表型和分泌细胞因子的变化,以研究SOCS在PBC发病机制中的作用。方法对10例PBC患者和8名健康人,用流式细胞术(FCM)分析其DC表型CD83、CD86和人类白细胞抗原DR(HLA—DR),用酶联免疫吸附测定法(ELISA)检测DC培养上清液中细胞因子白细胞介素一10(IL一10)、IL—12和干扰素-y(IFN-y)含量,用免疫印迹法(WB)测定DC中SOCSl和SOCS3水平;并评价分析这些指标在2组中的变化特征。结果PBC患者外周血中DC细胞表型CD83、CD86和HLA—DR的表达率分别为(79.4±4.8)%、(86.5±6.3)%和(90.0±3.5)%,均高于健康对照组的表达率[(68.3±4.1)%、(74.24-6.3)%和(83.6±7.6)%,t值分别为5.340、4.120和2.514,P均〈0.05];DC分泌的IL.12和IFN-y含量分别为(53.54-11.1)、(32.04-9.0)ng/L,与健康对照组的细胞因子含量[(32.1±10.7)、(15.4±8.1)ng/L]相比,IL-12和IFN-1均显著升高(t值分别为4.123和3.818,P均〈0.01);IL一10含量为(7.0±4.6)ng/L,与健康对照组[(5.8±4.2)ng/L]相比,差异无统计学意义(t=0.563,P〉0.05);WB检测PBC组DC中SOCSl和SOCS3的表达比健康对照组明显降低。结论PBC患者体内DC更倾向于成熟状态,其抗原递呈能力明显增强,SOCS的低表达可能与免疫平衡紊乱和免疫耐受破坏有关。r手华检验医学杂志,2012,35:216-220) Objective To study the role of suppressor of cytokine signaling (SOCS)in the pathogenesis of primary biliary cirrhosis( PBC ) , the levels of SOCS protein and the changes of function of dendritic cell(DC) were respectively observed from PBC patients. Methods The study population consisted of 10 patients of PBC and 8 healthy controls. Phenotypic analysis of cultured peripheral blood mononuclear cells (PBMC)-derived DC was performed by flow cytometry (FCM), such as CD83, CD86 and human leukocyte antigen DR(HLA-DR). The levels of iuterleukin-10 (IL-10) , interferon-~ ( IFN-7 ) and IL-12 in culture supernatant of DC were measured by enzyme linked immunosorbent assay ( ELISA ) . The protein levels of SOCS1 and SOCS3 were detected by Western blot ( WB ) . The features of changes in these parameters were analyzed between the two groups. Results The expression of CD83, CD86 and HLA-DR in PBC patients were (79.4 ±4. 8 ) % , ( 86. 5 ± 6. 3 ) % and ( 90. 0 ± 3.5 ) % , which were significantly higher than those in healthy control group[ (68.3 _+4. 1)%, (74. 2 ±6. 3)% and (83.6 +7.6)% ], respectively (t =5. 340,4. 120,2. 514,P 〈0. 05). The levels of IL-12 and IFN-y/ in PBC patients were (53.5 ±11.1 )and (32. 0 +9. 0) ng/L, which were significantly higher than those in healthy control group[ (32. 1 ± 10. 7) and (15.4 ±8.1 ) ng/L; t = 4. 123,3. 818 ,P 〈 0.011. There were not any significant difference of IL-10 level between PBC patients [ ( 7.0 ± 4. 6 ) ng/L ] and the healthy controls [ ( 5.8 ± 4. 2 ) ng/L ;t -- 0. 563, P 〉 0. 05 ]. The proteins levels of SOCS1 and SOCS3 in PBMC-derived DC from PBC group were decreased significantly than those in healthy control group. Conclusions The results suggest that the PBMC-derived DC in PBC patients has greater ability of potent maturation and antigen presentation function. The decreased expression of SOCS levels may be associated with the excessive immunological reaction and the breakdown of self-tolerance. (Chin J Lab Med, 2012,35:216-220)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2012年第3期216-220,共5页 Chinese Journal of Laboratory Medicine
基金 国家高技术研究发展计划(863计划)资助项目(2006AA022496)
关键词 肝硬化 胆汁性 树突细胞 细胞因子类 细胞因子信号转导蛋白抑制因子 Liver cirrhosis, biliary Dendritic cells Cytokines Suppressor of cytokinesignaling proteins
  • 相关文献

参考文献3

二级参考文献38

  • 1Kenichi Nomura,Yoshio Sumida,Takaharu Yoh,Atsuhiro Morita,Yosuke Matsumoto,SawakoTaji,NaohisaYoshida,MasahitoMinami,YoshitoItoh,ShigeoHoriike,Keisho Kataoka,Masafumi Taniwaki,Takeshi Okanoue.Lack of evidence for leukocyte maternal microchimerism in primary biliary cirrhosis[J].World Journal of Gastroenterology,2004,10(16):2415-2416. 被引量:2
  • 2Selmi C,Mayo M J,Bach N,et al.Primary biliary cirrhosis in monozygotic and dizygotic twins:genetics,epigenetics,and environment[J].Gastroenterology,2004,127:485-492.
  • 3Takii Y,Nakamura M,Ito M,et al.Enhanced expression of type Ⅰ interferon and toll-like receptor-3 in primary biliary cirrhosis[J].Lab Invest,2005,85:908-920.
  • 4Ehlers M,Raveteh J V.Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance[J].Trends Immunol,2007,28(2):74-79.
  • 5Pr(e)le C M,Woodward E A,Bisley J,et al.SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages[J].J Immunol,2008,181(11):8018-8026.
  • 6Dalpke A,Heeg K,Bartz H,et al.Regulation of innate immunity by suppressor of cytokine signaling(SOCS)proteins[J].Immunobiology,2008,213(3-4):225-235.
  • 7Starr R,Willson A T,Viney E M,et al.A family of cytokine inducible inhibitors of signaling[J].Nature,1997,387(6636):917-921.
  • 8Heathcote E J.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines[J].Hepatology,2000,31:1005-1013.
  • 9Harada K,Isse K,Kamihira T,et al.Th1 cytokine-induced down regulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis[J].Hepatology,2005,41(6):1329-1338.
  • 10Roelofs M F,Joosten L A,Abdollahi-Roodsaz S,et al.The expression of toll-like receptors 3 and 7 in rheumatold arthritis synovium is increased and costimulation of toll-like receptors 3,4,and 7/8 results in synergistic cytokine production by dendritic cells[J].Arthritis Rheum,2005,52(8):2313-2322.

共引文献24

同被引文献33

  • 1姜小华,仲人前,方晓云,安峰,胡寅,汪修平,孔宪涛.抗线粒体抗体M2抗原诱导小鼠原发性胆汁性肝硬化模型的建立[J].中华肝脏病杂志,2006,14(3):202-204. 被引量:13
  • 2Kaplan MM, Gershwin ME. Primary biliary cirrhosis[J]. N Engl J Med, 2005, 353(12):1261-1273.
  • 3Selmi C,Bowlus CL,Gershwin ME,et al. Primary bili-ary cirrhosis [ J ]. Lancet,2011,377 (9777 ) : 1600-1609.
  • 4Yoshimura A, Naka T, Kubo M. SOCS proteins, cyto-kine signalling and immune regulation [ J]. Nat RevImmunol,2007 , 7(6) ;454-465.
  • 5Tamiya T, Kashiwagi I, Takahashi R,et al. Suppressorsof cytokine signaling (SOCS) proteins and JAK/STATpathways : regulation of T-cell inflammation by SOCS1and S0CS3[ J]. Arterioscler Thromb Vase Biol,2011,31(5) :980-985.
  • 6Elkord E,Williams PE,Kynaston H,et al. Humanmonocyte isolation methods influence cytokine produc-tion from in vitro generated dendritic cells[ J]. Immu-nology, 2005, 114(2) :204-212.
  • 7Tsuda M, Ambrosini YM, Zhang W, et al. Fine pheno-typic and functional characterization of effector clusterof differentiation 8 positive T cells in human patientswith primary biliary cirrhosis [ J]. Hepatology,2011 ,54(4) :1293-1302.
  • 8Selmi C, Meroni PL, Gershwin ME. Primary biliarycirrhosis and Sjogrenrs syndrome: autoimmune epithe-litis[ J]. J Autoimmun,2012,39(1-2) :34-42.
  • 9Gershwin ME , Mackay IR. The causes of primarybiliary cirrhosis : convenient and inconvenient truths[J]. Hepatology, 2008,47(2) :737-745.
  • 10Migliaccio C,Van de Water J,Ansari AA, et al.Heterogeneous response of antimitochondrial autoanti-bodies and bile duct apical staining monoclonal anti-bodies to pyruvate dehydrogenase complex E2 : themolecule versus the mimic[ J]. Hepatology, 2001,33(4):792-801.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部